核糖核酸
生物
转移RNA
DNA
枯草芽孢杆菌
劈理(地质)
非编码RNA
分子生物学
博莱霉素
逆转录酶
生物化学
基因
遗传学
古生物学
细菌
化疗
断裂(地质)
作者
B J Carter,Erik de VROOM,Eric C. Long,G. A. VAN DER MAREL,Jacques H. VAN BOOM,Sidney M. Hecht
标识
DOI:10.1073/pnas.87.23.9373
摘要
Bleomycin is an antitumor agent whose activity has long been thought to derive from its ability to degrade DNA. Recent findings suggest that cellular RNA may be a therapeutically relevant locus. At micromolar concentrations, Fe(II)-bleomycin readily cleaved a Bacillus subtilis tRNAHis precursor in a highly selective fashion, but Escherichia coli tRNA(Tyr) precursor was largely unaffected even under more forcing conditions. Other substrates included an RNA transcript encoding a large segment of the reverse transcriptase from human immunodeficiency virus 1. RNA cleavage was oxidative, approximately 10-fold more selective than DNA cleavage, and largely unaffected by nonsubstrate RNAs. RNA sequence analysis suggested recognition of RNA tertiary structure, rather than recognition of specific sequences; subsets of nucleotides at the junction of single- and double-stranded regions were especially susceptible to cleavage. The ready accessibility of cellular RNAs to xenobiotic agents, the high selectivity of bleomycin action on RNAs, and the paucity of mechanisms for RNA repair suggest that RNA may be a therapeutically relevant target for bleomycin.
科研通智能强力驱动
Strongly Powered by AbleSci AI